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Abstract
INTRODUCTION: Polymorphism of CYP2E1 induces nasopharyngeal carcinoma (NPC) by activating pro-
carcinogens including nitrosamine. Environmental factor such as salted fish, preserved food, tobacco, and alcohol 
consumption which contains nitrosamine, join with CYP2E1 polymorphism leads to an increase of susceptibility for 
NPC.
OBJECTIVE: The aims of this study were to identify CYP2E1 polymorphism and the association with other risk 
factors to NPC in NPC patients.
METHODS: This study was analytic research with the case–control design. The samples were taken based on non-
probability consecutive sampling method. The identification of CYP2E1 polymorphism was done by the PCR-RFLP 
method. The association of its variable to NPC was analyzed with the Chi-square test and between polymorphism of 
CYP2E1 with other risk factors was analyzed with stratified analysis.
RESULT: We found that there was no significant association of CYP2E1 polymorphism with NPC. However, the joint 
effect of CYP2E1 polymorphism with smoking was significant in NPC patients. The risk for NPC in the combination 
of those two was 4.0-fold.
CONCLUSION: The study showed the capability of genetics and environment in the development of NPC. Further 
study can be done to find evidence of genetics and environmental influence in the prevention and treatment of NPC.
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Introduction
Nasopharyngeal carcinoma (NPC) arising 
from nasopharynx epithelium and is developed by the 
relation of genetic, Epstein–Barr virus (EBV) infection, 
and environment [1], [2]. NPC has a unique geographic 
distribution which common in South China and Southeast 
Asia [3], [4]. There were 86.500 cases of NPC and 50.000 
deaths due to NPC worldwide [5]. In Indonesia, there 
are about 13.000 cases of NPC per year [6]. Based on 
age-standardized rate, there were 8.3/100.000 in males 
and 3.0/100.000 in females for the incidence of NPC in 
Indonesia based on GLOBOCAN 2012 [7]. The disease is 
in the fourth rank for the most common cancer in Indonesia 
and the most frequent for head and neck cancer [8].
Genetic, EBV infection and the influence of the 
environment had been known as the etiology of NPC [9]. 
The distinct pattern for distribution of NPC was thought 
as the result of genetic and environment interaction [10]. 
Contribution of genetics in the development of NPC 
includes alteration of the chromosomal regions and 
genes and also epigenetic alteration such as DNA 
methylation [11]. Genetic polymorphism was also known 
to be associated with NPC. Cytochrome P450 2E1 
(CYP2E1) is an enzyme works in activating nitrosamine 
and related carcinogen metabolism. Polymorphism of 
this enzyme which is homozygote mutant genotype 
(−/−) is associated with increased risk of NPC [10], [12]. 
This polymorphism is related to the increased enzyme 
activity of CYP2E1 [12].
Clear geographic distribution of NPC is related 
to the dietary habit of the population in the endemic area 
including salted fish and preserved food consumption. This 
diet contains nitrosamine as carcinogen. However, smoking 
also has a role in the development of NPC [13], [14]. 
Nitrosamine, besides it is contained in the food, also can 
be found in tobacco [15]. This carcinogen is a genotoxic 
carcinogen that induces DNA mutation, leading to 
malignancy development [16], [17]. We did the study to 
analyze the role of genetic, polymorphism of CYP2E1, and 
environment as the risk factor for NPC patients in General 
Hospital Haji Adam Malik Medan. There was no study about 
this in Medan. The result can be used as the basic data 
of the further studies ahead in analyzing the interaction of 
other genetics factors of NPC with the risk factor. Therefore, 
it can support that intervention of the genetic and risk factor 
of NPC is important in the treatment and prevention of NPC.
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Materials and Methods
Patients and samples
The study was analytic research with a 
case–control design. The case group was the NPC 
patients diagnosed based on history taking, physical 
examination and histopathological evaluation in the 
Department of Otorhinolaryngology, Head and Neck 
Surgery, Adam Malik General Hospital Medan. The 
control group was with the same frequency with the 
case group and does not have a history of cancer. The 
inclusion criteria were the NPC patients who agreed to 
be the participants in the study and the exclusion criteria 
were the NPC patients who have other malignancies. 
The interview was done to obtain information on the risk 
factors of NPC patients.
The samples of the study were the DNA 
extracted from 2 ml of blood taken from the NPC 
patients and the controls. The identification of CYP2E1 
polymorphism by PCR-RFLP was done in the Integrated 
Laboratory of the Faculty of Medicine of Universitas 
Sumatera Utara. The blood was collected in EDTA blood 
collection tubes and then performed DNA extraction 
using the Wizard Genomic DNA Purification Kit 100 
Isolation® (PROMEGA, United States of America).
PCR-RFLP analysis
DNA isolation product was used for PCR 
analysis. We used a method from the usage information 
of the GoTaq® Green Master Mix for amplification. 
There was 25 μl total reaction volume with each sample 
consisted of 12.5 μl of the GoTaq® Green Master Mix, 
1 μl of forwarding primer, 1 μl of reverse primer, 2 μl of 
DNA template, and 8.5 μl nuclease-free water. We used 
the PCR method by Ghania et al. to identify CYP2E1 
polymorphism using Rsal digestion [12]. This study used 
5’-CCAGTCGAGTCTACATTGTCA-3’ as the forward 
primer and 5’-TTCATTCTGTCTTCTAAC-TGG-3’ as the 
reverse primer. There were 40 cycles in this PCR method 
with the thermal condition of 92°C for 1 min, 60°C for 1 min, 
72°C for 2 min, and final elongation at 72°C for 5 min. 
Then, it continued with the RFLP method by digestion of 
5 μl of samples with 0.2 μl Rsal at 37°C overnight. We 
continued electrophoresis using agarose gel 2% and 
visualized the bands under ultraviolet transilluminator.
Statistical analysis and ethics
The data were analyzed using the Statistical 
Package for the Social Sciences (SPSS) 23.0 computer 
program. The distributions of the cases and controls were 
analyzed using the Chi-square test. The association of 
CYP2E1 polymorphism with other risk factors to NPC 
was analyzed using stratification analysis with the value 
for a risk factor that was mentioned with OR (odds 
ratio). The result was said to be statistically significant if 
the two-sided p < 0.05. This study has been approved 
by the Health Research Ethical Committee, Medical 
Faculty of Universitas Sumatera Utara/Adam Malik 
General Hospital and the methods did not contradict 
with the Declaration of Helsinki.
Results
In the study, we found there were 21 (56.8%) 
patients in the age group of 41–60 years old. It had 
the highest number than any age group. Male was 
dominant than the female with a comparison of 2.7:1. 
We found that WHO type 2, non-keratinizing squamous 
cell carcinoma was the most common histopathological 
type of NPC in the study with 23 (62.2%) patients. In 
control, age group of 41–60 years old had a higher 
number with 21 (56.8%) persons, and slightly different 
from the age group of 21 to 40 years old with 16 (43.2%) 
persons. The data are shown in Table 1.
Table 1: Demographic distribution based on age, gender, and 
histopathological type
Characteristics Case (%) Control (%)
Age (years old)
<21 0  0
21–40 13 (35.1) 16 (43.2)
41–60 21 (56.8) 21 (56.8)
>60 3 (8.1) 0
Gender  
Male 27 (73.0) 15 (40.5)
Female 10 (27.0) 22 (59.5)
Histopathological type
WHO type I 5 (13.5)
WHO type II 23 (62.2)  
WHO type III 9 (24.3)
Table 2 shows several risk factors of NPC 
and its distribution in the NPC patients and non-NPC 
patients. We found that homozygous wild type genotype 
(+/+) was the most common for CYP2E1 genotype with 
24 (64.9%) patients in case and 26 (70.3%) in control. 
This genotype had the band which is visualized in the 
50 bp and 360 bp. The heterozygous mutant genotype 
(±) resulted in the presence of band in 50 bp, 360 bp, 
and 410 bp. We found 3 (8.1%) NPC patients and 
5 (13.5%) persons with this type of CYP2E1 genotype. 
There were 10 (27.0%) NPC patients and 6 (16.2%) 
persons carrying homozygous mutant genotype (−/−) 
in this study. This genotype resulted in the presence of 
band in 410 bp.
Table 2: Distribution of CYP2E1 polymorphism and other risk 
factors in case and control and the risk for NPC
O risk factor Case (%) Control (%) p value OR (CI 95%)
CYP2E1 genotype
+/+ 24/37 (64.9) 26/37 (70.3) >0.05
+/− 3/37 (8.1) 5/37 (13.5) >0.05
−/− 10/37 (27.0) 6/37 (16.2) >0.05
Smoking  
+ 23/37 (62.2) 12/37 (32.4) <0.05* 3.423 (1.315–8.909)
− 14/37 (37.8) 25/37 (67.6)
Drinking alcohol
+ 4/37 (10.8) 2/37 (5.4)
− 33/37 (89.2) 35/37 (94.6) >0.05
Salted fish and preserved food consumption
+ 28/37 (75.7) 29/37 (78.4)
− 9/37 (24.3) 8/37 (21.6) >0.05
*Chi-square test. NPC=Nasopharyngeal carcinoma, OR: Odds ratio, CI: Confidence interval.
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Based on the smoking status, in NPC patients, 
there was a higher number of smokers than non-smokers 
with 23 (62.2%) smokers and 14 (37.8%) non-smokers. 
However, in controls, smokers were less than non-smokers 
with 12 (32.4%) smokers and 25 (67.6%) non-smokers. 
Alcohol drinkers were less than non-drinkers both in NPC 
patients and controls. Alcohol drinkers in NPC patients 
were 4 (10.8%) patients and in controls were 2 (5.4%) 
persons while non-alcohol drinkers were 33 (89.2%) in 
NPC patients and 35 (94.6%) persons in controls. The 
frequent consumption of salted fish and preserved food 
was found in 28 (75.7%) in NPC patients and 29 (78.4%) in 
controls. There were 9 (24.3%) NPC patients and 8 (21.6%) 
persons of controls which were not frequently consuming 
salted fish and preserved food consumption. We found 
a significant association of smoking with NPC with a risk 
of 3.423-fold higher in smokers than non-smokers. There 
was no significant association of CYP2E1 polymorphism, 
drinking alcohol, and salted fish and preserved food 
consumption with NPC.
We analyzed the joint effect of CYP2E1 
polymorphism with other environmental risk factors in 
NPC patients which are shown in Table 3. The result 
was there was a significant association of the joint of 
homozygote mutant genotype of CYP2E1 with smoking 
in NPC patients (OR = 4.000, 95% CI = 1.205–13.283, 
p = 0.007). It meant that in the person carrying 
homozygous mutant genotype of CYP2E1, the 
incidence of NPC differed between smokers and 
non-smokers with the risk in smokers was about four-
fold higher than smokers. Above, the risk for NPC in 
smoking alone was about 3.423 and the combination of 
smoking and homozygote mutant genotype was higher, 
about four. We did not find a significant association of 
the joint of CYP2E1 polymorphism with drinking alcohol 
and the consumption of salted fish and preserved food.
Table 3: Association of CYP2E1 polymorphism with 
environmental factors in NPC patients
Risk factors Genetic variance of CYP2E1
+/+ +/− −/−
Case/
Control
p 
value
Case/
Control
p 
value
Case/
Control
p 
value
Smoking
Smokers 13/10 >0.05 2/2 >0.05 8/0 <0.05** 
(OR:4.000) 
CI: 1.205–13.283
Non-smokers 11/16 1/3 2/6
Drinking alcohol
Drinkers 2/1 >0.05 1/1 >0.05 1/0 >0.05
Non-drinkers 22/25 2/4 9/6
Salted fish and preserved food consumption
Frequently 18/21 >0.05 3/3 7/5 >0.05
Seldom 6/5 0/2 >0.05 3/1
**Fisher’s exact test. NPC: Nasopharyngeal carcinoma, OR: Odds ratio, CI: Confidence interval.
Discussion
In the study, we found that most NPC patients 
were frequently had age in the range of 41–60 years old 
and then followed by the age in the range of 21–40 years 
old. The result was similar to studies which had been 
done before. Wei et al. in their study of incidence and 
mortality of NPC in China found that incidence of NPC 
rose quickly in the age with a range of 25–29 years old 
with the peak age was in the range of 60–64 years old 
in males and 75–79 years old in females. The incidence 
than was decreased in the older range of age [18]. 
Adham et al., in Indonesia, found that the patients were 
diagnosed with NPC in the range of age 30–59 years 
old with the peak age was at 40–49 years old [8]. 
However, in the western area, Finland, Ruuskanen 
et al., found the range of age in the diagnosis of NPC 
was in 12–85 years old with the average age was 
57 years old [19]. The incidences of NPC in the Asian 
as the high-risk populations rise in adolescences with 
the peak age at 45–55 years old and then decline. In 
the low risk and intermediate populations, the western 
area, the incidences have a bimodal pattern where the 
first peak at age 15–24 years old and the second peak 
at 65–79 years old. The bimodality pattern was thought 
due to the heterogeneous etiology of NPC within the 
same populations [20].
Male was common suffering NPC than 
females in this study with the ratio 2.7:1. Xiao et al. 
found 213 (71.2%) males and 86 (28.8%) females 
with NPC [21]. Xie et al. found that the overall ratio of 
male to female for NPC was ranged in 2.2–3.1. Male 
is dominant for NPC was thought related to a delayed 
development of cancer in females, especially before 
menopause. The protective effect of estrogen was 
thought has a role in that suggestion. Environmental 
factors such as smoking and salted fish and preserved 
food consumption are mainly found in males. It also 
thought of as the reason for the predominantly male in 
NPC [22].
In this study, non-keratinizing squamous cell 
carcinoma was found mostly from other histopathology 
types. This type is the most common in the endemic 
area about more than 95% cases [23], [24]. It is 
associated with EBV infection and more radiosensitive 
than other types [23], [25]. Keratinizing squamous cell 
carcinoma is common in the west area with low EBV, 
DNA is detected in patients with this histopathology 
type. This type is associated with smoking and has a 
poorer prognosis than non-keratinizing squamous cell 
carcinoma [26], [27]. Pan et al., in Singapore, found 103 
of 111 NPC patients with non-keratinizing squamous 
cell carcinoma [28]. A study by Ji et al., in China, also 
found most histopathology type of NPC in their study 
was non-keratinizing squamous cell carcinoma with 
932 of 1044 NPC patients [29].
Tobacco contains carcinogens, nitrosamines, 
and an active carcinogen metabolite that damaging DNA 
and induces chronic inflammation in nasopharyngeal 
mucosa [30]. Tobacco- specific nitrosamine is the 
highly carcinogenic substances in tobacco which is 
the product of nitrosation of nicotine that is contained 
in tobacco. Nitrosamine ketone (NNK) is one of the 
active carcinogens of tobacco-specific nitrosamine. 
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It causes a mutation of oncogenes such as K-Ras 
and p53. Besides, NNK is also responsible for the 
modulation of signal-transducing networks such as the 
PI3K-Akt pathway. The pathway increases cell growth, 
proliferation, survival, migration, and metabolism [31].
In this study, the risk for NPC in smokers 
was 3.423 fold higher than non-smokers. A study by 
Ekburanawat et al. found that a significant association 
of smoking with NPC with the risk was 2.41-fold higher 
than non-smokers. The study also was similar to our 
findings that there was no significant association 
between alcohol and salted fish consumption with 
NPC [32]. A meta-analysis study by Xue et al. found an 
increased risk of NPC about 1.6-fold for smokers than 
non-smokers. Smokers with a cumulative exposure of 
≥30 pack-years had a higher risk for NPC, 2.93-fold 
than smokers with cumulative exposure <30 pack-
years which had the risk for NPC about 1.29-fold than 
non-smokers [33].
CYP2E1 acts in the activation of pro-carcinogens 
including nitrosamines which are contained in tobacco, 
meat, and salted and preserved food [34], [35], [36]. 
This enzyme metabolizes the xenobiotic substances 
into toxic substances which induces carcinogens [37]. 
CYP2E1 also can induce ROS formation that can 
damaging DNA, leading to mutation and increased 
cell growth [38], [39]. Polymorphism of CYP2E1 
had known to be associated with cancers including 
NPC [40], [41], [42], [43]. The polymorphism increases 
the transcription and activity of CYP2E1. Therefore, the 
activation of pro-carcinogens such as nitrosamine also 
increased [42], [43]. The type of CYP2E1 polymorphism 
which has higher enzyme activity is homozygous 
mutant genotype (−/−) [12]. In our study, there was no 
association of CYP2E1 polymorphism to NPC while 
the joint effect of this genetic variance with smoking 
was found to be significantly associated with NPC with 
the risk 4.0-fold higher in smokers than non-smokers. 
A similar result was found by Ghania et al. in their study 
that showed an increased risk for NPC which 3.3-fold 
higher in smokers than non-smokers in patients carrying 
homozygous mutant genotype [12].
Conclusion
We found that NPC patients were mostly 
male in the age group of 41–60 years old. The most 
common histopathology type was non-keratinizing 
squamous cell carcinoma. Among the risk factors, 
smoking was found associated with NPC while others 
were not related to NPC. However, the combination 
of the homozygous mutant genotype of CYP2E1 with 
smoking had a significant association with NPC that 
there was increased the risk for NPC in smokers which 
carrying homozygous mutant genotype.
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